La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Flywire a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Flywire..

Flywire (NASDAQ:FLYW) Azioni, Catena delle Opzioni

FLYWIRE CORP-VOTING

Flywire

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

wall street chart shutter2

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

ACTG

FLYW

LPRO

Il mercato offre occasioni uniche: ecco le società con un forte potenziale di crescita, nonostante i recenti ribassi.

3 azioni finanziarie a prezzi stracciati da aggiungere al portafoglio?

Flywire Corporation - Voting Common Stock

Flywire Corp

FLYWHEEL ADVANCED TECH by Flywheel Advanced Technology Inc.

Flywheel Advanced Technology Inc

Macro Economic Events

Economics

Federal Reserve

Fed's Barkin Says Not Convinced Higher Prices Won't Be Passed On, Or That There Won't Be Inflation; To Cut Rates You Need Confidence On Inflation; Higher The Inflation Numbers, The Less Likely You'll See That; 1970s Stagflation Was Characterized By Out-of-whack Inflation Expectations; Not Seeing That Now

WIIM

APPS

ARQQ

ASML

CDNS

CMTL

COHR

CSAI

DELL

DGNX

ENPH

ENTG

FSLY

GOOG

INTC

INTZ

IVDA

LAES

LDTC

LITE

LMFA

MPWR

NTNX

OKTA

OLED

OUST

PCOR

Penguin Solutions, Inc. - Ordinary Shares

PENG

PLTR

PRSO

SAIL

SEDG

SHOP

SNCR

SNOW

SNPS

TDTH

UBXG

Shares of companies in the broader technology sector are trading lower as President Trump declares that reciprocal tariffs will target all countries.

Nowadays, the new White House administration continues putting pressure on BigTech through active antitrust enforcement, trying to establish control over the technological sector, which notably depends on foreign companies. Many fintech firms may also attract government attention due to adopting decentralized technologies and partnering with global players. This growing tension could possibly pose a significant threat to fintech companies, which have to both stay compliant with evolving regulatory frameworks and maintain their development pace.
To understand possible consequences better, let's examine key BigTech cases and explore how the fintech industry could be affected.
BigTech Antitrust Cases
This situation around BigTech and antitrust issues against it appeared even before the new White House administration took office. During Joe Biden's administration, several noticeable cases were introduced, targeting major technology companies. These legal campaigns involved such corporations as Google, Amazon and Apple. Let's take a closer look at them.
In January 2023, the U.S. Department of Justice (DOJ) <a href="https://www.justice.gov/archives/opa/pr/justice-department-sues-google-monopolizing-digital-advertising-technologies">initiated</a> an antitrust lawsuit against Google. The case puts emphasis on Google's influential presence in the digital advertising technology market and its growing activity in acquisitions of companies within the industry. Therefore, the main purpose of this lawsuit is to ensure a more balanced and competitive environment for advertisers and publishers. At this time, the court hasn't issued a final ruling on the case yet.
Ten months later, in September 2023, the Federal Trade Commission (FTC)<a href="https://www.ftc.gov/news-events/news/press-releases/2023/09/ftc-sues-amazon-illegally-maintaining-monopoly-power"> took</a> legal action against Amazon, raising concerns about the company's practices to limit competition in the market. According to the lawsuit, such things as high seller fees, search result rankings and discounting policies are key points of discussion, as they may influence fair competition and limit the potential of other businesses. This antitrust lawsuit against Amazon is also in progress. Most recently, in March 2024, the U.S. DOJ <a href="https://www.justice.gov/archives/opa/pr/justice-department-sues-apple-monopolizing-smartphone-markets">initiated</a> an antitrust lawsuit involving Apple, addressing concerns about the monopolization of the smartphone market. The case explores how particular strategies may impact consumer choice and costs for developers and businesses. As of now, the case remains ongoing.
In reality, the current administration <a href="https://www.reuters.com/technology/artificial-intelligence/trump-announce-private-sector-ai-infrastructure-investment-cbs-reports-2025-01-21/">supports</a> the rapid development of the technological sector. However, ongoing antitrust cases that involve major technology companies continue to be accurately reviewed. Undoubtedly, both BigTech and fintech are drawing considerable attention from the current U.S. administration. Still, the economy and trade have historically been given higher priority, as they are more essential for long-term stability and growth. Subsequently, decisions regarding fintech could be driven by what is more important for the economy and development.
The Impact on Fintech Amid BigTech's Antitrust Scrutiny
It makes sense to examine the impact on the fintech industry in this paragraph and define how it's affected. Despite Donald Trump's administration promoting a favourable agenda for fintech development, the sector remains a part of the White House's wider assessment. As a result, concerns may appear in the near future, especially since fintech companies often use non-American technologies, such as China's DeepSeek and form partnerships with BigTech corporations that may raise questions.
According to the global <a href="https://www.grandviewresearch.com/horizon/outlook/artificial-intelligence-in-fintech-market-size/global">outlook</a> for the artificial intelligence market in fintech, it was valued at $9.5 billion in 2021 and is projected to grow at a compound annual growth rate of 16.5% from 2022 to 2030. Fintech companies intensively adopt AI in their projects and actively work on the development and integration of AI technologies across their workflows. So, companies are open to <a href="https://thefintechtimes.com/deepseek-everyones-talking-about-it-industry-takes-you-might-have-missed/">working</a> with foreign technologies, such as China's DeepSeek. However, the use of Chinese AI could cause distrust for fintech firms if it results in dependency on foreign technologies or fair competition's notable impact. Eventually, it could lead to legal limitations on access to such technologies and the promotion of ideas to impose additional regulation.
Speaking about partnerships of fintech firms with BigTech corporations, it's worth noting that working with Google and Apple Pay alongside Amazon payment services could also result in significant changes in policies that might complicate transaction processing. In addition, if BigTech corporations are forced to reduce fees or open access to third-party wallets, fintech firms that rely on current payment solutions could bring considerable financial losses.
What Is Next for Fintech?
As the attention to antitrust regulations for BigTech corporations keeps growing, fintech firms should remain vigilant. It's important for them to evaluate potential risks and devise plans on how to adjust to changes in the regulatory landscape that could appear from the White House's increased scrutiny of the sector. Although the Trump administration has been supporting fintech and fostering a positive regulatory framework, this does not guarantee that future decisions of the White House won't affect this sector.

Fintech news covering the emerging Financial Technology services sector

Fintech

Opinion

Tech

Out Of Nowhere: Can BigTech's Antitrust Troubles Disrupt FinTech?

Logistics giant United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) launched a new platform that will provide upfront costs, including the impact <a href="https://www.benzinga.com/government/regulations/25/02/43711974/trump-launches-plan-for-reciprocal-tariffs-sp-500-nears-record-highs-dollar-tumbles-as-investors-cheer-on-late-kickoff">of any tariffs</a>, for consumers on international purchases.
What Happened: UPS recently launched UPS Global Checkout, enabling consumers to view the impact <a href="https://www.benzinga.com/markets/equities/25/03/44554008/wall-street-on-edge-futures-slide-ahead-of-trumps-liberation-day-tariff-shock">of tariffs imposed</a> by President Donald Trump on various countries before placing an order.
The service is launching in 43 countries and guarantees the cost of customs fees and duties on international purchases, UPS <a href="https://about.ups.com/us/en/newsroom/press-releases/customer-first/ups-unveils-game-changing-ups--global-checkout--no-more-surprise.html">said</a>.
UPS launched the platform in response to shoppers frequently facing unexpected fees for unpaid import costs after placing international orders. The launch also comes ahead of Trump's self-proclaimed "Liberation Day" on April 2, when he plans to announce reciprocal tariffs on multiple countries.
"With UPS Global Checkout, we're making international shopping around the world as easy as buying in-store," UPS EVP and President of International, Healthcare and Supply Chain Solutions Kate Gutmann said.
Gutmann said that UPS Global Checkout allows online shoppers to have "peace of mind" when they pay at checkout because they will not be subject to additional fees.
"This, combined with our total UPS premium delivery experience, benefits our customers – the retailers – by helping to drive additional sales."
Read Also: <a href="https://www.benzinga.com/trading-ideas/25/03/44566164/exclusive-could-trumps-liberation-day-reciprocal-tariffs-crash-the-stock-market-48-say-this">EXCLUSIVE: Could Trump&#8217;s &#8216;Liberation Day&#8217; Reciprocal Tariffs Crash The Stock Market? 48% Say This</a>
Why It's Important: UPS is the only global integrated carrier with a guaranteed cost structure for international shipping, according to the company.
The platform adjusts to policy changes, duties and tariffs in real time, which could be helpful given the ever-changing world of tariffs and the percent levied on certain countries and industries.
"Given trade shifts around the world, expanding growth opportunities in new markets can now be seamless," Gutmann said.
UPS highlighted a survey of U.S. and UK shoppers that found that 41% of shoppers avoided international e-commerce purchases if the duties and taxes were not clear at checkout.
With Trump set to place additional tariffs on items and countries, UPS's new tool could come at the perfect time and help the logistics company land new deals and partnerships as more consumers worry about not paying extra fees after purchase.
UPS Price Action: United Parcel Service stock traded at $110.25 on Monday versus a 52-week trading range of $108.30 to $154.29. The stock hit a new 52-week low on Monday, and shares are down 11.4% year-to-date.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43712690/exclusive-will-trumps-chinese-tariffs-help-or-hurt-americas-economy-54-say-this">EXCLUSIVE: Will Trump&#8217;s Chinese Tariffs Help Or Hurt America&#8217;s Economy? 54% Say This…</a></li>
</ul>
Photo: Shutterstock

Global

UPS Offers 'Peace Of Mind With No Surprises' With Transparent Tariff Cost Tool

Fed's Williams Says Tariffs Will Impact Prices; Consumer Goods Should See Quick Pass Through From Tariffs; Intermediate Goods Could See Slow Impact From Tariffs; There Is Definitely A Risk To Inflation Being Higher That Fed Forecasts; My Forecast That Inflation Will Be Relatively Stable This Year With Upside Risks

Workday's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NYSE">WDAY</a>) short percent of float has risen 6.44% since its last report. The company recently reported that it has 8.14 million shares sold short, which is 3.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Workday Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743448528_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Workday has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Workday's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Workday's peer group average for short interest as a percentage of float is 3.04%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

WDAY

Looking Into Workday's Recent Short Interest

Edison Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) short percent of float has fallen 7.64% since its last report. The company recently reported that it has 8.52 million shares sold short, which is 2.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.07 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Edison Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743448522_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Edison Intl has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Edison Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Edison Intl's peer group average for short interest as a percentage of float is 2.27%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Edison Intl Gaining or Losing Market Support?

PNC Financial Services Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) short percent of float has risen 5.66% since its last report. The company recently reported that it has 4.41 million shares sold short, which is 1.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>PNC Financial Services Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743448517_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PNC Financial Services Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PNC Financial Services Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, PNC Financial Services Gr's peer group average for short interest as a percentage of float is 1.23%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into PNC Financial Services Gr's Recent Short Interest

Fed's Barkin Says It's Going To Take A While Before We Get Clarity On Tariff Impact; Suppliers Are Emboldened, Say They Will Have To Pass On Higher Prices; Consumers Say They Are Tired Of Paying Higher Prices

Goldman Sachs analyst Eric Sheridan attended the 2025 Shoptalk Conference in Las Vegas from March 25 to March 27.
Based on his conversations with companies and industry participants, the analyst shared his key takeaways across <a href="https://www.benzinga.com/topic/e-commerce" target="_blank" rel="noreferrer noopener">eCommerce, digital advertising</a>, retail, and software:
Also Read: <a href="https://www.benzinga.com/25/02/43431559/amazon-temu-and-shein-under-eu-scrutiny-regulators-target-illegal-products-and-tougher-e-commerce-rules" target="_blank" rel="noreferrer noopener">Amazon, Temu, and Shein Under EU Scrutiny, Regulators Target Illegal Products and Tougher E-Commerce Rules</a>
<ul>
<li>Search is evolving to meet rising customer expectations.</li>
<li>The future of eCommerce is conversational and personalized.</li>
<li>Video content is becoming critical from awareness to conversion.</li>
<li>AI is enabling a better brand experience.</li>
<li>Retail media is increasingly a differentiator.</li>
<li>The in-store environment remains an opportunity for retail media dollars ahead.</li>
<li>There are signs of stable demand for digital transformation but less visibility into the second quarter.</li>
</ul>
Sheridan&#8217;s internet picks:
<ul>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Buy with $255 price target</li>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Buy with $220 price target</li>
<li>Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Buy with $765 price target) and </li>
<li>Pinterest, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) Buy with $47 price target</li>
</ul>
Retail top picks:
<ul>
<li>SharkNinja, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) Buy, with a $133 price target</li>
<li>GAP Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) Buy with a $34 price target and </li>
<li>Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) Buy with $106 1price target.</li>
</ul>
Software picks:
<ul>
<li>Shopify Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>) Buy with a $150 price target and </li>
<li>Klaviyo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) Buy with a $51 price target.</li>
</ul>
Google continues to play an essential role in online commerce. Google and YouTube are present in 2/3rd of journeys where consumers discover new brands, products, or retailers.
Google was aligned with this vision of the future of multimodal search and spoke to their focus on Google Lens, which now serves over 20 billion monthly queries. Text-based search remains normative, and generative AI products augment the experience.
Amazon is also experimenting with visual search with Amazon Lens and is pleased with the various ways shoppers engage with the product, which suggests that users are deriving value from it.
Amazon launched its AI shopping assistant, Rufus, in 2024.
Google launched a more conversational version of Google Shopping last October. Over 1 billion people shop across Google every day, and the company sees Google Shopping as an essential part of its broader commerce strategy.
Walmart noted an opportunity to enhance the customer experience by cross-functionally driving its retail media stream. This collaboration across retail media, data, marketing, and other customer experiences will drive profit while enabling a frictionless customer experience.  
Sheridan expects Shopify to see traction in B2B due to the market&#8217;s legacy replacement cycle and relatively benign competitive backdrop.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44539949/disney-analyst-sees-profit-growth-ahead-with-streaming-gains-park-recovery-big-film-releases" target="_blank" rel="noreferrer noopener">Disney Analyst Sees Profit Growth Ahead With Streaming Gains, Park Recovery, Big Film Releases</a></li>
</ul>
Image: Shutterstock

Analyst Ratings

AMZN

GOOGL

KVYO

PINS

Shoptalk 2025: Goldman Sachs Analyst Unveils Insights On AI, Video, Retail And Stock Picks

Fed's Williams Says Full Impact Of Tariffs Can Play Out Over Long Horizon

Fed's Williams Says It's Early Days In Figuring Out Impact Of Tariffs; There Is Still A Lot Of Uncertainty Around Tariffs, Details Matter; Need To Watch Data To Measure Impact Of Tariffs

Stock and ETF investors, take note. <a href="https://www.benzinga.com/topic/peter-schiff">Peter Schiff </a>sees trouble ahead and he's not mincing words. The renowned investor warns that the government and financial media are &#8220;making the same mistake again&#8221; as they did before the 2008 Global Financial Crisis, Schiff wrote <a href="https://x.com/PeterSchiff/status/1906690596640600283">on</a> X.
The culprit this time? A toxic mix of tariffs, rising interest rates and misguided Federal Reserve policies that could unleash an economic firestorm.
<h2 class="wp-block-heading">Tariffs: A Recipe For Inflation, Rate Hikes</h2>
Schiff argues that tariffs won't just impact trade &#8211; they'll send shockwaves through the economy. &#8220;Tariffs mean fewer goods will come into the country, and fewer dollars will go out. More money chasing fewer goods means higher domestic prices. This is an economic certainty,&#8221; he said.
For investors, that translates to higher inflation, a weaker consumer and pressure on corporate margins.
But it doesn't stop there. &#8220;Lower trade deficits will result in fewer dollars being recycled into U.S. bonds, sending long-term interest rates higher.&#8221; With higher rates, borrowing costs rise for businesses and consumers alike, slowing growth and putting pressure on stocks—especially high-flying tech names.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44309742/recession-watch-small-caps-sound-the-alarm-but-credit-markets-shrug">Recession Watch: Small Caps Sound The Alarm, But Credit Markets Shrug</a>
<h2 class="wp-block-heading">Fed To The Rescue? Not So Fast</h2>
Schiff sees the Federal Reserve making the wrong move when the economy starts showing signs of strain. &#8220;The Fed will respond to this &#8216;unexpected&#8217; economic weakness with rate cuts, ignoring the surge in consumer prices as a transitory effect of tariffs.&#8221; 
Translation? Inflation won't just persist &#8211; it could spiral. And if the Fed resorts to quantitative easing (QE) again, Schiff warns, &#8220;throwing gasoline on an already burning inflation fire&#8221; could create a crisis far worse than 1970s-style stagflation.
<h2 class="wp-block-heading">What It Means For Investors</h2>
If Schiff's prediction plays out, stock investors should brace for turbulence. High-growth and rate-sensitive sectors like technology, as tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) and the Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>), could face pressure. On the other hand, inflation-resistant assets &#8211; such as:
Commodities, as tracked by the Invesco DB Commodity Index Tracking Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBC#NYSE">DBC</a>); Gold, as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), and select energy stocks &#8211; may become safe havens.
Bond investors and those invested in popular Treasury tracking ETFs such as iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>), the Vanguard Total Bond Market ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BND#NASDAQ">BND</a>) and the iShares Core U.S. Aggregate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGG#NYSE">AGG</a>) beware: rising long-term rates could send Treasury prices tumbling.
Meanwhile, a &#8220;weaker dollar and larger budget deficits&#8221; could mean international ETFs and hard assets outperform U.S. equities.
<h2 class="wp-block-heading">Is This The Next 2008?</h2>
Schiff isn't predicting a simple market correction &#8211; he's warning of something much worse. &#8220;This will not be 1970s-style stagflation. It will be something much worse.&#8221; 
If history is about to repeat itself, as he suggests, investors who ignore the warning signs could be caught in the fire. The question is: Are you ready?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44456554/trade-wars-fed-moves-and-a-40-recession-risk-is-your-portfolio-ready">Trade Wars, Fed Moves And A 40% Recession Risk &#8211; Is Your Portfolio Ready?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Bonds

Broad U.S. Equity ETFs

Specialty ETFs

ETFs

PowerShares DBmmodity Index Optimum Yield Diversified Fund

iShares Trust Barclays 20+ Year Treasury Bond Fund

Peter Schiff Sounds The Alarm: 'Same Mistake Again' Could Trigger Economic Firestorm

UBS initiates coverage on Bentley Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSY#NASDAQ">BSY</a>) with a Neutral rating and announces Price Target of $48.

Price Target

Initiation

UBS Initiates Coverage On Bentley Systems with Neutral Rating, Announces Price Target of $48

Vertex Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) announced on Friday updates about its type 1 diabetes (T1D) portfolio.
The company said it would not be advancing further in VX-264 clinical trials. Vertex plans to conduct further analyses, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44545391/vertex-announces-program-updates-for-type-1-diabetes-portfolio" rel="noreferrer noopener">including of explanted devices</a>.
<ul>
<li>Vertex completed enrollment and dosing in Parts A and B of the&nbsp;Phase 1/2 VX-264 (cells + device) study and the planned analysis at Day 90 for Part B.</li>
<li>In Part B of the study, participants received the full dose of the investigational fully differentiated pancreatic islet cell therapy encapsulated in a proprietary immunoprotective device.</li>
<li>In Part B, there were two primary endpoints: safety and change in peak C-peptide during a mixed-meal tolerance test (MMTT) from baseline at Day 90.</li>
<li>VX-264 was generally safe and well tolerated; however, the study did not meet the efficacy endpoint.</li>
<li>Increases in C-peptide, a marker of insulin production, were not observed at levels necessary to deliver benefit.</li>
</ul>
Zimislecel (formerly VX-880), Vertex&#8217;s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the Phase 1/2/3 study in patients with T1D with severe hypoglycemic events (SHEs) and impaired awareness of hypoglycemia.
<ul>
<li>The is on track to complete enrollment and dosing in the first half of 2025, setting up global regulatory submissions in 2026.</li>
</ul>
Vertex is investing in expanding its manufacturing and commercial capabilities to ensure launch readiness. If approved, eligible patients across the U.S. and Europe with recurrent SHEs despite best available care could benefit from zimislecel. Vertex anticipates that initial approval could serve approximately 60,000 people with severe T1D.
Vertex is also pursuing research-stage T1D programs. These approaches include alternative immunosuppressive regimens, gene-edited hypoimmune stem-cell derived islet cell therapies, and novel devices to encapsulate islet cells.
William Blair wrote,&#8221;We view the discontinuation of VX-264 as disappointing given that this would have expanded Vertex's type 1 diabetes market significantly from that being addressed from zimislecel; however, we did not ascribe any value for the early-stage program in our model. Vertex's prioritization on the clinical advancement and potential launch of zimislecel for 60,000 severe T1D patients is prudent given the positive data to date, and approval in the T1D space would serve to further the company's diversity of commercial assets beyond cystic fibrosis and acute pain.&#8221;
Analyst Myles Minter reiterated <a href="https://www.benzinga.com/quote/VRTX/analyst-ratings" target="_blank" rel="noreferrer noopener">an Outperform rating</a>.
VRTX Price Action: Vertex stock was down 2.09% at $482.36 at publication Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/03/44566809/eli-lillys-cholesterol-drug-reduces-genetic-heart-disease-risk-factor-by-93-9" target="_blank" rel="noreferrer noopener">Eli Lilly&#8217;s Cholesterol Drug Reduces Genetic Heart Disease Risk Factor By 93.9%</a></li>
</ul>
Photo: Shutterstock

Biotech

Health Care

General

VRTX

Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data

Corcept Therapeutics Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) announced on Monday that the ROSELLA Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer met its primary endpoint of improved progression-free survival, as assessed by blinded independent <a href="https://www.benzinga.com/general/biotech" target="_blank" rel="noreferrer noopener">central review (PFS-BICR)</a>.
In ROSELLA, patients treated with relacorilant and nab-paclitaxel chemotherapy experienced a 30% reduction in the risk of disease progression compared to patients treated with nab-paclitaxel alone.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42483672/corcept-therapeutics-fda-approved-korlym-hits-main-goal-in-cushings-syndrome-patients-with-difficult-to-control-diabetes" rel="noreferrer noopener">Corcept Therapeutics&#8217; FDA-Approved Korlym Hits Main Goal In Cushing&#8217;s Syndrome Patients With Difficult-To-Control Diabetes</a>
The median PFS-BICR was 6.5 months, compared to 5.5 months in patients who received <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44559343/primary-endpoint-met-in-corcepts-pivotal-phase-3-rosella-trial-of-relacorilant-in-patients-with-pl" rel="noreferrer noopener">nab-paclitaxel alone</a>.
At an interim evaluation of overall survival (OS), patients treated with relacorilant plus nab-paclitaxel had a significant improvement in OS, with a median OS of 16.0 months, compared to 11.5 months for patients receiving nab-paclitaxel alone.
Relacorilant was well-tolerated and no new safety signals were observed.
The complete results of ROSELLA will be presented at a medical conference this year.
The ROSELLA trial enrolled 381 patients with platinum-resistant ovarian cancer.
Analyst Reaction:
<ul>
<li>HC Wainwright maintains Corcept Therapeutics with a Buy, raising the price target <a href="https://www.benzinga.com/quote/CORT/analyst-ratings" target="_blank" rel="noreferrer noopener">from $115 to $150</a>.</li>
<li>Truist Securities maintains Corcept Therapeutics with a Buy, raising the price target from $76 to $150.</li>
</ul>
Price Action: CORT is up 85.6% at $101.80 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44544148/hb-fuller-faces-growth-hurdles-jp-morgan-analyst-slashes-price-forecast-amid-declining-sales-in-health-hygiene-and-consumable-segment" target="_blank" rel="noreferrer noopener">JP Morgan Slashes H.B. Fuller Price Forecast For Softening Growth</a></li>
</ul>
Photo: Shutterstock

Movers

CORT

Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecast

11 analysts have expressed a variety of opinions on DocuSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $97.73, a high estimate of $124.00, and a low estimate of $73.00. A decline of 1.64% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1743447689_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of DocuSign by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$105.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$124.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$73.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Brad Sills</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$98.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$124.00</td>
<td>$124.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to DocuSign. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of DocuSign compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of DocuSign's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of DocuSign's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DOCU/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on DocuSign analyst ratings.</a>
<h2>All You Need to Know About DocuSign</h2>
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
<h3>DocuSign: A Financial Overview</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining DocuSign's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.97% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: DocuSign's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 10.76%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): DocuSign's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 4.18%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): DocuSign's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 2.15%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: DocuSign's debt-to-equity ratio is below the industry average at 0.06, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DOCU

11 Analysts Have This To Say About DocuSign

Deep-pocketed investors have adopted a bullish approach towards AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ABBV usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 23 extraordinary options activities for AbbVie. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 43% leaning bullish and 21% bearish. Among these notable options, 16 are puts, totaling $1,740,435, and 7 are calls, amounting to $359,373.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $180.0 to $220.0 for AbbVie over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of AbbVie stands at 3048.78, with a total volume reaching 10,547.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AbbVie, situated within the strike price corridor from $180.0 to $220.0, throughout the last 30 days.
<h3>AbbVie 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743447675_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$8.3</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$185.00</td>
<td>$410.0K</td>
<td>114</td>
<td>500</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$3.15</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$195.00</td>
<td>$305.0K</td>
<td>2.7K</td>
<td>1.2K</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$200.00</td>
<td>$161.6K</td>
<td>4.1K</td>
<td>327</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$4.05</td>
<td>$3.9</td>
<td>$3.97</td>
<td>$205.00</td>
<td>$134.9K</td>
<td>694</td>
<td>1.2K</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$3.25</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$205.00</td>
<td>$91.4K</td>
<td>694</td>
<td>558</td>
</tr>
</tbody>
</table>

<h3>About AbbVie</h3>
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
In light of the recent options history for AbbVie, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of AbbVie</h3>
<ul>
<li>Currently trading with a volume of 4,607,370, the ABBV's price is up by 1.79%, now at $208.96. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 25 days.</li>
</ul>
<h3>What The Experts Say On AbbVie</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $231.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on AbbVie with a target price of $240. 
&#x2A; An analyst from B of A Securities has decided to maintain their Neutral rating on AbbVie, which currently sits at a price target of $223. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AbbVie options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

ABBV

Decoding AbbVie's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bearish approach towards Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TEAM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Atlassian. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 50% bearish. Among these notable options, 4 are puts, totaling $144,411, and 4 are calls, amounting to $145,781.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $260.0 for Atlassian during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Atlassian stands at 387.0, with a total volume reaching 2,441.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Atlassian, situated within the strike price corridor from $200.0 to $260.0, throughout the last 30 days.
<h3>Atlassian 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743447669_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEAM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$17.7</td>
<td>$17.6</td>
<td>$17.6</td>
<td>$210.00</td>
<td>$49.2K</td>
<td align="right">539</td>
<td>50</td>
</tr>
<tr>
<td>TEAM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$8.1</td>
<td>$7.0</td>
<td>$7.4</td>
<td>$215.00</td>
<td>$46.6K</td>
<td align="right">4</td>
<td>63</td>
</tr>
<tr>
<td>TEAM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$0.45</td>
<td>$0.2</td>
<td>$0.2</td>
<td>$260.00</td>
<td>$44.8K</td>
<td align="right">263</td>
<td>2.2K</td>
</tr>
<tr>
<td>TEAM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$59.9</td>
<td>$59.1</td>
<td>$59.66</td>
<td>$250.00</td>
<td>$35.7K</td>
<td align="right">131</td>
<td>28</td>
</tr>
<tr>
<td>TEAM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$60.5</td>
<td>$59.5</td>
<td>$59.95</td>
<td>$250.00</td>
<td>$29.9K</td>
<td align="right">131</td>
<td>41</td>
</tr>
</tbody>
</table>

<h3>About Atlassian</h3>
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
After a thorough review of the options trading surrounding Atlassian, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Atlassian Standing Right Now?</h3>
<ul>
<li>With a volume of 1,312,954, the price of TEAM is down -2.8% at $211.88. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 24 days.</li>
</ul>
<h3>What The Experts Say On Atlassian</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $295.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Stephens &amp; Co. downgraded its rating to Equal-Weight, setting a price target of $255. 
&#x2A; An analyst from Jefferies has decided to maintain their Buy rating on Atlassian, which currently sits at a price target of $330. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Atlassian with a target price of $300. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Atlassian with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

TEAM

A Closer Look at Atlassian's Options Market Dynamics

In the latest quarter, 30 analysts provided ratings for Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">11</td>
<td align="right">16</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">9</td>
<td align="right">11</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $210.37, a high estimate of $235.00, and a low estimate of $190.00. This current average has increased by 7.06% from the previous average price target of $196.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1743447666_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Snowflake. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$190.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$210.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$215.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$200.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$221.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$228.00</td>
<td>$201.00</td>
</tr>
<tr>
<td>John Vinh</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$220.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$210.00</td>
<td>$187.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$203.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Ittai Kidron</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$215.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$205.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$205.00</td>
<td>$186.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$230.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$210.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Bradley Sills</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$205.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Alex Zukin</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$235.00</td>
<td>-</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$201.00</td>
<td>-</td>
</tr>
<tr>
<td>Ittai Kidron</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$208.00</td>
<td>$185.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Snowflake. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Snowflake compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Snowflake's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SNOW/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Snowflake analyst ratings.</a>
<h2>All You Need to Know About Snowflake</h2>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
<h3>Financial Insights: Snowflake</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, Snowflake showcased positive performance, achieving a revenue growth rate of 27.37% as of 31 January, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Snowflake's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -33.19%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -11.05%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Snowflake's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -3.8%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.9, Snowflake adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 30 Analysts Discuss Snowflake Stock

Legal

Press Releases

Bragar Eagel & Squire, P.C. Is Investigating Lion Electric, Flywire, Civitas, and SoundHound and Encourages Investors to Contact the Firm

FLYW Investors Have Opportunity to Lead Flywire Corporation Securities Fraud Lawsuit

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Flywire Corporation Investors to Inquire About Securities Class Action Investigation - FLYW

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Flywire, Civitas, and SoundHound and Encourages Investors to Contact the Firm

Flywire Corporation Investor News: If You Have Suffered Losses in Flywire Corporation (NASDAQ: FLYW) You Are Encouraged to Contact The Rosen Law Firm About Your Rights

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation - FLYW

Cash-Rich Ultra Luxury Travelers Boost Spend, Seek Wellness in 2025, Flywire Survey Reveals

Flywire Corporation Announcement: If You Have Suffered Losses in Flywire Corporation (NASDAQ: FLYW) You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Comments

Flywire

Flywire (FLYW) Opzioni

Flywire (NASDAQ:FLYW) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO